Jennison Associates LLC Moderna, Inc. Transaction History

Jennison Associates LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$117.13 - $176.59 $2.06 Million - $3.1 Million	-17,579 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$126.46 - $235.05 $1.57 Million - $2.92 Million	12,426 Added 241.14%	17,579 $3.03 Million
Q4 2021 Feb 08, 2022	BUY	$225.82 - $368.51 $635,909 - $1.04 Million	2,816 Added 120.5%	5,153 $1.31 Million
Q3 2021 Nov 09, 2021	SELL	$221.9 - $484.47 $3.11 Million - $6.8 Million	-14,030 Reduced 85.72%	2,337 $899,000
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $2.13 Million - $3.85 Million	16,367 New	16,367 $3.85 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.